Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospital Universitari de Bellvitge
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Breast cancer patients with an indication for axillary lymphadenectomy according to the multidisciplinary team:
cN0 with positive sentinel lymph node biopsy (pN+) requiring axillary lymphadenectomy: cT3; More than two axillary macrometastases; or patients undergoing mastectomy without indication for adjuvant radiotherapy
cN1: Primary surgery; or after neoadjuvant therapy without complete axillary response and/or positive TAD (ypN+)
cN2: Primary surgery; or after neoadjuvant therapy in luminal tumors and/or without complete axillary response in triple-negative or HER2-positive tumors, and/or positive TAD (ypN+)
You may not be if
Patients with prior axillary radiotherapy
Patients with suspected metastatic involvement based on palpation of ARM lymph nodes during the surgical procedure
Patients participating in other studies whose primary objective depends on local axillary treatment
